Hong-Jie Jhou

32PUBLICATIONS
45CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursEpidemiological methodsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 26, 2026
Immune Checkpoint Inhibitor Therapy and Risk of Glomerular Disease: A Large Propensity-Matched Cohort Study.

|Jul 16, 2026
Effect of Remdesivir on Mortality in Mechanically Ventilated COVID-19 Patients: A Target Trial Emulation Using Inverse Probability of Treatment Weighting.

|Jun 11, 2026
Target Trial Emulation of Second-Generation Versus First-Generation Tyrosine Kinase Inhibitors in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

|May 06, 2026
Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

|Jan 26, 2026
Contrast-Associated Acute Kidney Injury After Endovascular Therapy for Acute Ischemic Stroke: A Meta-Analysis.

Hong-Jie Jhou, Po-Huang Chen, Li-Yu Yang

|Dec 11, 2025
Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030.

Yu-Han Chen, Lindsay Fogel, Andrea Yue-En Sun

Pageof 6

Frequent Collaborators

25 joint publications

Po-Huang Chen

15 joint publications

Cho-Hao Lee

4 joint publications

Wei-Cheng Chang

3 joint publications

Ming-Shen Dai